Clinical Trials on Myelinated Nerve and Unmyelinated Nerve Study in China

Total 667 results

Xinhua Hospital, Shanghai Jiao Tong University...

Unknown

Study of Tomotherapy HD in Medulloblastoma

Medulloblastoma

China
Nanjing First Hospital, Nanjing Medical University

Recruiting

A Prospective Phase II Efficacy and Safety Study of Anlotinib in Metastatic or Locally Advanced Pheochromocytoma/ Paraganglioma : Open-label Single-arm, Exploratory Trial (EASOAIPPGL)

Advanced or Metastatic Paraganglioma/ Pheochromocytoma

China
Huashan Hospital
Shanghai Cell Therapy Research Institute

Active, not recruiting

Adoptive Cell Therapy of Autologous TIL and PD1-TIL Cells for Patients With Glioblastoma Multiforme

Glioblastoma Multiforme

China
Xuanwu Hospital, Beijing

Unknown

Genomic Landscape of Intramedullary Astrocytoma (GIMA)

Spinal Cord Astrocytoma

China
Beijing Tiantan Hospital
Beijing Shijitan Hospital, Capital Medical University; Beijing Neurosurgical...

Unknown

CCRT With Temozolomide Versus RT Alone in Patients With IDH Wild-type/TERT Promoter Mutation Grade II/III Gliomas

Grade II/III Glioma

China
Xinhua Hospital, Shanghai Jiao Tong University...

Unknown

Radiation Therapy and Combination Chemotherapy for Medulloblastoma

Medulloblastoma

China
Hoffmann-La Roche

Completed

Atezolizumab in Combination With Bevacizumab in Patients With Unresectable Locally Advanced or Metastatic Mucosal Melanoma

Melanoma

China
Fuda Cancer Hospital, Guangzhou
Shenzhen Hank Bioengineering Institute

Completed

High-activity Natural Killer Immunotherapy for Small Metastases of Melanoma

Melanoma

China
West China Hospital

Not yet recruiting

Study of Adaptive Radiotherapy for High-grade Glioma Based on Interfraction MRI

High-grade Glioma

China
Dushu Lake Hospital Affiliated to Soochow University

Recruiting

Natural Killer (NK) Cells (XS005) Injection Combined With Stupp Regimen for Adjuvant Chemotherapy in Subjects With Primary Glioblastoma(GBM)

Glioblastoma | GBM

China
West China Hospital

Recruiting

Radiotherapy Versus Radiotherapy Combined With Temozolomide in High-risk Low-grade Gliomas After Surgery

Low-grade Glioma

China
Peking Union Medical College Hospital

Recruiting

Prediction and Evaluation of Anlotinib Treatment Response Using Contrast Enhanced Ultrasound PPGL Patients

Ultrasonography | Pheochromocytoma, Metastatic | Paraganglioma, Malignant | Pheochromocytoma Malignant

China
Sun Yat-sen University

Recruiting

Efficacy of Post-radiation Adjuvant Temozolomide Chemotherapy in Residue Low-grade Glioma

Astrocytoma | Oligodendroglioma | Oligodendroastrocytoma

China
Guangdong Provincial People's Hospital
Novartis

Unknown

Safety and Tolerability Profile of RAD001 Daily in Chinese Patients With Advanced Pulmonary Neuroendocrine Tumor

Neuroendocrine Tumors | Carcinoid Tumor

China
WuHui

Unknown

Clinical Study of Apatinib Combined With Temozolomide in the Treatment of Uncontrolled or Repeated High-grade Gliomas

High-grade Gliomas

China
Tang-Du Hospital

Unknown

Noninvasively Predicting Gene Status of Glioma (NPGSOG)

Glioma of Brain

China
The Third Xiangya Hospital of Central South University
Beijing Capture Technology Co., Ltd

Unknown

In-hospital Neutron Irradiator (IHNI)-Based Boron Neutron Capture Therapy (BNCT) in the Treatment of Malignant Melanoma

Melanoma | Boron Neutron Capture Therapy

China
Binhui Biopharmaceutical Co., Ltd.

Recruiting

OH2 Injection in Combination With HX008 for Melanoma.

Melanoma

China
CANbridge Life Sciences Ltd.

Recruiting

Phase 2 Study of CAN008 in Subjects With GBM

Newly-diagnosed Glioblastoma

China
Shanghai 10th People's Hospital
Jilin University; Ganzhou City People's Hospital

Recruiting

Integrative Analysis of Human Glioblastoma Multiforme

GBM

China
Peking University

Terminated

Study to Compare Irinotecan Combined With Cisplatin (IP) Versus Etoposide Combined With Cisplatin (EP) in Advanced and Metastatic Gastrointestinal Pancreatic and Esophageal Neuroendocrine Carcinoma

Neuroendocrine Carcinoma

China
Peking University

Unknown

Study to Evaluate the Efficiency of SOX as Seconde-line Chemotherapy in Neuroendocrine Carcinoma

Neuroendocrine Carcinoma

China
Biotech Pharmaceutical Co., Ltd.
Sun Yat-sen University

Completed

Nimotuzumab Plus Radiotherapy With Concomitant and Adjuvant Temozolomide for Cerebral Glioblastoma

Glioblastoma

China
Jinsong Wu

Completed

Molecular Pathology Research Project of Glioma

Glioma, Malignant

China
Hutchison Medipharma Limited

Unknown

HMPL-813 in Treating Patients With Glioblastoma

Glioblastoma

China
Jinsong Wu

Completed

Multi-center Research Project for Glioma Molecular Pathology Intraoperative Rapid Detection

Glioma, Malignant

China
Peking University Cancer Hospital & Institute

Unknown

Phase II Study in the Treatment of Patients With Advanced Mucinous Melanoma (BJCH-MM-0624)

Advanced Mucosal Melanoma

China
Suzhou Zelgen Biopharmaceuticals Co.,Ltd

Recruiting

Study of ZG005 in Combination With Etoposide and Cisplatin in Participants With Advanced Neuroendocrine Carcinoma.

Neuroendocrine Carcinoma

China
Tianjin Medical University General Hospital

Recruiting

Evaluate the Efficacy and Safety of Atorvastatin Combined With Temozolomide in the Treatment of Glioblastoma

Glioblastoma, IDH-wildtype

China
Peking Union Medical College Hospital

Not yet recruiting

Elemene Plus Stupp Protocol Versus Stupp Protocol Alone for Newly-diagnosed Glioblastoma

Glioblastoma, IDH-wildtype

China
Beijing Tiantan Hospital

Unknown

The Impact of Anesthesia on High- Grade Glioma Patients

Anesthesia, Outcome, High-grade Glioma

China
Peking University

Unknown

Study to Evaluate the Efficiency of FOLFIRI as Seconde-line Chemotherapy in Neuroendocrine Carcinoma

Neuroendocrine Carcinoma

China
Zhuan Zhang

Completed

Effect of Stellate Ganglion Block Combined With Facial Nerve Block on the Treatment of Idiopathic Facial Paralysis

Peripheral Facial Palsy

China
Shenzhen Geno-Immune Medical Institute
Shenzhen Children's Hospital; Shenzhen Hospital of Southern Medical University

Unknown

Immunotherapy Based on Antigen-specific Immune Effector Cells Targeting Neurofibromatosis or Schwannomatosis

Cancer

China
Mingge LLC
Fudan University; Huashan Hospital

Active, not recruiting

Intraoperative Rapid Diagnosis of Glioma Based on Fusion of Magnetic Resonance and Ultrasound Imaging

Glioma, Malignant | Computer-Assisted Surgery

China
Nanjing Jinling Hospital

Unknown

Differentiation of Progression From Treatment Effects in High-Grade Gliomas: A Clinical Trial With Multimodality MR Imaging

Glioma

China
Huashan Hospital

Active, not recruiting

Hypofractionated Stereotactic Radiotherapy With Anlotinib in Patients With Recurrent High-Grade Gliomas

Malignant Glioma

China
Beijing Sanbo Brain Hospital

Completed

Glioblastoma Response Prediction to Apatinib

Glioblastoma

China
Cure&Sure Biotech Co., LTD
Beijing Tiantan Hospital

Completed

Research for Immunotherapy of Glioblastoma With Autologous Heat Shock Protein gp96

Glioma

China
Henan Provincial People's Hospital

Not yet recruiting

Sintilimab (One Anti-PD-1 Antibody) Plus Low-dose Bevacizumab for ctDNAlevel- Relapse and Clinical-relapse Astrocytoma

Astrocytoma of Brain

China
Second Affiliated Hospital, School of Medicine,...
Hangzhou Normal University

Not yet recruiting

Pilot Study of Elemene in Treating Patients With Refractory Glioblastoma

Refractory Glioblastoma

China
Zhejiang Cancer Hospital

Unknown

Trial of Hypofractionated Intensity Modulated Radiation Therapy With Temozolomide and Granulocyte-macrophage Colony-stimulating Factor for Patients With Newly Diagnosed Glioblastoma Multiforme

Glioblastoma Multiforme

China
Beijing Tiantan Hospital

Recruiting

Safety and Efficacy Study of Anti-B7-H3 CAR-T Cell Therapy for Recurrent Glioblastoma

Glioblastoma

China
Huashan Hospital

Completed

Bevacizumab and Nimustine in Patients With Recurrent High Grade Glioma

Glioblastoma

China
Sichuan University

Recruiting

Tumor Treating Fields for Newly Diagnosed Glioblastoma: Two Emulated Trials With Chinese Multi-Hospital Based Real-World Data

Glioblastoma Multiforme

China
Jiangsu HengRui Medicine Co., Ltd.

Recruiting

An Open-label Phase 3 Study of Lutetium (177Lu) Oxodotreotide Injection in Subjects With Advanced Gastrointestinal Pancreatic Neuroendocrine Tumors.

Advanced Gastroenteropancreatic Neuroendocrine Tumor

China
Novartis Pharmaceuticals

Completed

Safety and Efficacy of RAD001 in Chinese Patients With Advanced Pulmonary Neuroendocrine Tumor (\MACS1304)

Lung Neuroendocrine Neoplasm

China
Huashan Hospital
Shanghai Municipal Science and Technology Commission

Completed

Functional Monitoring for Motor Pathway in Brain Tumor Surgery Within Eloquent Area

Glioma, Motor Pathway

China
Beijing Tiantan Hospital
ZhongSheng BioTech Inc.

Active, not recruiting

Safety & Efficacy of DC Vaccine and TMZ for the Treatment of Newly-diagnosed Glioblastoma After Surgery

Glioblastoma Multiforme of Brain

China
Peking Union Medical College Hospital

Unknown

Recurrence Rates of Type I Gastric Neuroendocrine Tumors Treated With Long-acting Somatostatin Analogs

Gastric NET

China

3

Subscribe